Events and Presentations Events and Presentations Past Events H.C.Wainwright 5th Annual NeuroPerspectives Virtual Conference Jun 27, 2024 at 7:00 AM EDT Listen to webcast Supporting Materials H.C.Wainwright 5th Annual NeuroPerspectives Virtual Conference Presentation 3.7 MB Presentations ESMO 2024 Poster - Results of the Phase 1b Study of NC410 Combined with Pembrolizumab in Ovarian Cancer Patients August 2024 Corporate Presentation H.C.Wainwright 5th Annual NeuroPerspectives Virtual Conference Presentation June 2024 Corporate Presentation ASCO 2024 Poster - A Phase 1b Study of NC410 in Combination with Pembrolizumab in Immune Checkpoint Inhibitor (ICI) Naïve, and Refractory Microsatellite Stable (MSS)/Microsatellite Instability-Low (MSI-L) Colorectal Cancer (CRC) and Ovarian Cancer Tools
Events and Presentations Past Events H.C.Wainwright 5th Annual NeuroPerspectives Virtual Conference Jun 27, 2024 at 7:00 AM EDT Listen to webcast Supporting Materials H.C.Wainwright 5th Annual NeuroPerspectives Virtual Conference Presentation 3.7 MB Presentations ESMO 2024 Poster - Results of the Phase 1b Study of NC410 Combined with Pembrolizumab in Ovarian Cancer Patients August 2024 Corporate Presentation H.C.Wainwright 5th Annual NeuroPerspectives Virtual Conference Presentation June 2024 Corporate Presentation ASCO 2024 Poster - A Phase 1b Study of NC410 in Combination with Pembrolizumab in Immune Checkpoint Inhibitor (ICI) Naïve, and Refractory Microsatellite Stable (MSS)/Microsatellite Instability-Low (MSI-L) Colorectal Cancer (CRC) and Ovarian Cancer
H.C.Wainwright 5th Annual NeuroPerspectives Virtual Conference Jun 27, 2024 at 7:00 AM EDT Listen to webcast Supporting Materials H.C.Wainwright 5th Annual NeuroPerspectives Virtual Conference Presentation 3.7 MB
ESMO 2024 Poster - Results of the Phase 1b Study of NC410 Combined with Pembrolizumab in Ovarian Cancer Patients
ASCO 2024 Poster - A Phase 1b Study of NC410 in Combination with Pembrolizumab in Immune Checkpoint Inhibitor (ICI) Naïve, and Refractory Microsatellite Stable (MSS)/Microsatellite Instability-Low (MSI-L) Colorectal Cancer (CRC) and Ovarian Cancer
